Home > Insider Trading > Filing (0000310764-25-000010)

Filing Details

Accession Number:: 0000310764-25-000010
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2025-02-04 19:36:37
Reporting Period:: 2025-01-31

Accepted Time:: 2025-02-04 19:36:37
Original Submission Date:: 2025-02-03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310764	Stryker Corp	SYK	Surgical & Medical Instruments & Apparatus (3841)	381239739

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242914	E Ronda Stryker	1941 Stryker Way Portage MI 49002		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-01-31	96,728	$390.89	3,746,739	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	38,802	$391.89	3,707,937	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	7,462	$392.69	3,700,475	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	18,283	$393.97	3,682,192	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	51,454	$394.85	3,630,738	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	11,058	$395.90	3,619,680	No	4	S	Indirect	By Revocable Trust
Common Stock	Disposition	2025-01-31	12,213	$396.69	3,607,467	No	4	S	Indirect	By Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust
No	4	S	Indirect	By Revocable Trust

Footnotes

This amendment is being filed to correct the number of shares sold (and applicable transaction prices) on January 31, 2025.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $390.39 to $391.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $391.385 to $392.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $392.38 to $393.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $393.38 to $394.375, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $394.38 to $395.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $395.39 to $396.385, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $396.39 to $397.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.